EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening

Grigorii V Andrianov iD, Emeline Haroldsen iD, John Karanicolas

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Grigorii V Andrianov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Hauptthemen laut MEDLINE: Machine Learning, Software. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, W. M. Keck Foundation, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The enthusiastic adoption of make-on-demand chemical libraries for virtual screening has highlighted the need for methods that deliver improved hit-finding discovery rates. Traditional virtual screening methods are often inaccurate, with most compounds nominated in a virtual screen not engaging the intended target protein to any detectable extent. Emerging machine learning approaches have made significant progress in this regard, including our previously described tool vScreenML. The broad adoption of vScreenML was hindered by its challenging usability and dependencies on certain obsolete or proprietary software packages. Here, we introduce vScreenML 2.0 to address each of these limitations with a streamlined Python implementation. Through careful benchmarks, we show that vScreenML 2.0 outperforms other widely used tools for virtual screening hit discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningSoftwareDrug DiscoverySmall Molecule LibrariesHumansDrug Evaluation, PreclinicalUser-Computer Interface

Stichwörter der Autor:innen

drug discoverymachine learningvirtual screening

Substanzen

Small Molecule Libraries

Autor:innen und Institutionen

  • Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
  • Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
  • Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA 19140, USA.

ORCID-Profile: Grigorii V Andrianov, Emeline Haroldsen

Förderung

  • NIGMS NIH HHS
  • W. M. Keck Foundation
  • NCI NIH HHS
  • W.M. Keck Foundation
  • NIH/NCI Cancer Center
  • Extreme Science and Engineering Discovery Environment (XSEDE)
  • National Science Foundation

Zitieren

APA

Andrianov, G. V., Haroldsen, E., & Karanicolas, J. (2024). vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212350

Vancouver

Andrianov GV, Haroldsen E, Karanicolas J. vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212350

BibTeX
@article{Andrianov2024,
  author = {Andrianov, Grigorii V and Haroldsen, Emeline and Karanicolas, John},
  title = {vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212350}
}
Kostenlos starten →